Bristol-Myers-Squibb acquisition of Celgene
On 3rd January 2019, Bristol-Myers Squibb announced that it was buying its rival Celgene for US$74bn in a stock and cash deal in one of...
top of page
About AIBC Global Research
At AIBC Global Research, we are committed to delivering the highest quality insights and analyses to enhance your learning experience. Our dedication ensures you have access to top-tier research, helping you delve deeper into the dynamic world of finance.
New to AIBC Global Research? We make a selection of insights throughout the year. Check out some of our recent content below or follow us on #aibcResearch via Linkedin.
Search
bottom of page